Knowledge Distillery

The objective of this study was to report the prevalence of acute encephalopathy and outcomes in patients with severe COVID-19, and to identify…

There is increasing evidence of both central and peripheral nervous system (PNS) involvement in COVID-19. In this systematic literature review the…

COVID-19 infection can impact the central nervous system, and is often associated with cognitive decline. However, there are no studies linking…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). About 45% of COVID-19 patients experience…

Guillain-Barré syndrome (GBS) is an immune-mediated polyradiculoneuropathy, often triggered by infection. The authors of this article aimed to…

The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more than four weeks after primary infection, termed "long COVID" or…

Neurological manifestations are common in COVID-19, the disease caused by SARS-CoV-2. Despite reports of SARS-CoV-2 detection in the brain and…

Several large-scale electronic health records studies have reported increased diagnostic rates for neuropsychiatric disorders following COVID-19…

The SARS-CoV-2 receptor, ACE2, is found on pericytes, contractile cells enwrapping capillaries that regulate brain, heart and kidney blood flow. ACE2…

Post COVID-19 conditions are complaints and symptoms in patients with a history of probable or confirmed COVID-19 after 3 months of the onset of…

Acute health events, including infections, can trigger the onset of functional neurological disorder (FND). In this article the authors hypothesised…

The objective of this retrospective nationwide cohort study was to determine the clinical sequelae of long covid for a year after infection in…